About UAS Labs
UAS Labs is a company based in Wausau (United States) founded in 1979 was acquired by Chr. Hansen in June 2020. UAS Labs has raised $31.75 million across 4 funding rounds from investors including Chr. Hansen and Greyrock Capital Group. UAS Labs has completed 2 acquisitions, including Micropharma and Nebraska Cultures. UAS Labs operates in a competitive market with competitors including Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.
- Headquarter Wausau, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Uas Life Sciences India Private Limited
- Date of Incorporation 21 Mar, 2014
- Jurisdiction Secunderabad, Telangana, India
-
Annual Revenue
$221.44 (USD)0as on Mar 31, 2016
-
Net Profit
-$124.36 K (USD)-27.29as on Mar 31, 2016
-
EBITDA
-$124.35 K (USD)-27.46as on Mar 31, 2016
-
Total Equity Funding
$31.75 M (USD)
in 4 rounds
-
Latest Funding Round
$4.5 M (USD), Series B
Feb 06, 2019
-
Investors
Chr. Hansen
& 1 more
-
Employee Count
Not available
-
Investments & Acquisitions
Micropharma
& 1 more
-
Acquired by
Chr. Hansen
(Jun 10, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of UAS Labs
UAS Labs has successfully raised a total of $31.75M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $4.5 million completed in February 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in UAS Labs
UAS Labs has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Chr. Hansen and Greyrock Capital Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provision of stable capital to private equity sponsors for investments.
|
Locked | Locked | Locked | |
|
Developer of natural solutions for the food, nutritional, pharmaceutical and agricultural industries.
|
Locked | Locked | Locked |
Investor details for UAS Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by UAS Labs
UAS Labs has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Micropharma and Nebraska Cultures.
Investment portfolio details for UAS Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Biotherapeutics for metabolic diseases are developed from bacteria.
|
Locked | Locked | 2004 | Locked | |
|
Information on various diseases is delivered via an online platform.
|
Locked | Locked | 1981 | Locked |
Complete acquisition details for UAS Labs
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - UAS Labs
Detailed financials for UAS Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Uas Labs Comparisons
Peer comparison for UAS Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of UAS Labs
UAS Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug discovery and development services for small molecules are provided.
|
|
| Locked | Locked | Locked |
CDMO services for pharma, biotech, and specialty ingredients are provided.
|
|
| Locked | Locked | Locked |
Pharmaceutical products for treating multiple diseases are provided.
|
|
| Locked | Locked | Locked |
Generic drugs and clinical research services are provided globally.
|
|
| Locked | Locked | Locked |
Laboratory testing, clinical trial research, and biopharma services are provided.
|
|
| Locked | Locked | Locked |
Novel point-of-care testing and low-dose interferon therapeutics are developed.
|
Detailed competitors of UAS Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Uas Labs
Complete news archive for UAS Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about UAS Labs
UAS Labs was founded in 1979 and raised its 1st funding round 34 years after it was founded.
UAS Labs is headquartered in Wausau, United States. It is registered at Wausau, Wisconsin, United States.
UAS Labs is a funded company, having raised a total of $31.75M across 4 funding rounds to date.
Annual revenue of UAS Labs is $221.44 as on Mar 31, 2016.
UAS Labs was founded in 1979 and is headquartered in Wausau, United States. Operations are centered in the biotechnology sector, with a focus on clinical research services and probiotic fermentation processes. These services support product development for health and nutrition applications. The company maintains facilities for research and manufacturing, serving clients in the probiotic and microbiome industries across North America.
UAS Labs has made 2 acquisitions, including Micropharma, and Nebraska Cultures.
UAS Labs has 2 investors. Key investors include Chr. Hansen, and Greyrock Capital Group.